1. Home
  2. SMBC vs DNA Comparison

SMBC vs DNA Comparison

Compare SMBC & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southern Missouri Bancorp Inc.

SMBC

Southern Missouri Bancorp Inc.

HOLD

Current Price

$60.35

Market Cap

613.1M

Sector

Finance

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$8.40

Market Cap

562.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMBC
DNA
Founded
1887
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
613.1M
562.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SMBC
DNA
Price
$60.35
$8.40
Analyst Decision
Hold
Strong Sell
Analyst Count
4
1
Target Price
$63.63
$9.00
AVG Volume (30 Days)
52.1K
983.9K
Earning Date
01-26-2026
11-06-2025
Dividend Yield
1.52%
N/A
EPS Growth
25.22
N/A
EPS
5.46
N/A
Revenue
$178,892,000.00
$180,606,000.00
Revenue This Year
$17.66
N/A
Revenue Next Year
$4.13
$7.28
P/E Ratio
$11.05
N/A
Revenue Growth
10.39
N/A
52 Week Low
$45.10
$5.00
52 Week High
$63.54
$17.58

Technical Indicators

Market Signals
Indicator
SMBC
DNA
Relative Strength Index (RSI) 56.56 42.10
Support Level $61.12 $8.09
Resistance Level $63.54 $9.12
Average True Range (ATR) 1.30 0.58
MACD -0.24 0.06
Stochastic Oscillator 43.59 19.60

Price Performance

Historical Comparison
SMBC
DNA

About SMBC Southern Missouri Bancorp Inc.

Southern Missouri Bancorp Inc is a USA-based holding company for Southern Missouri Savings Bank. The principal business of the bank consists of attracting retail deposits from the general public and using such deposits along with wholesale funding from the Federal Home Loan Bank of Des Moines, and to a lesser extent, brokered deposits, to invest in one- to four-family residential mortgage loans, mortgage loans secured by commercial real estate, commercial non-mortgage business loans, and consumer loans. It is engaged in providing the range of banking and financial services to individuals and corporate customers in its market areas. The company derives revenue principally from interest earned on loans, debt securities, bank card interchange fees, loan late charges and another fee income.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: